Screener
PJP vs IBB
Invesco Pharmaceuticals ETF vs iShares Biotechnology ETF
Key differences
- IBB costs 0.13% less per year.
- IBB is significantly larger than PJP — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PJP has delivered higher annualized returns.
Side-by-side comparison
| PJP | IBB | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.44% |
| Fund size (AUM) | $334M | $7.9B |
| Since | 2005 | 2001 |
| Dividend yield | 1.01% | 0.23% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +38.9% | +39.0% |
| CAGR 3Y | +14.0% | +9.6% |
| CAGR 5Y | +7.4% | +2.7% |
| Sharpe 3Y | 0.69 | 0.38 |
| Volatility 1Y | 16.19% | 19.75% |
| Max drawdown | -33.95% | -39.82% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and IBB
Explore further